PE20091453A1 - Compuestos como agentes antihelminticos o como intermediarios en la preparacion de agentes antihelminticos - Google Patents
Compuestos como agentes antihelminticos o como intermediarios en la preparacion de agentes antihelminticosInfo
- Publication number
- PE20091453A1 PE20091453A1 PE2008002081A PE2008002081A PE20091453A1 PE 20091453 A1 PE20091453 A1 PE 20091453A1 PE 2008002081 A PE2008002081 A PE 2008002081A PE 2008002081 A PE2008002081 A PE 2008002081A PE 20091453 A1 PE20091453 A1 PE 20091453A1
- Authority
- PE
- Peru
- Prior art keywords
- agents
- antihelmine
- nitro
- halogen
- atoms
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 4
- 150000002367 halogens Chemical class 0.000 abstract 4
- UTKUVRNVYFTEHF-UHFFFAOYSA-N 4-nitro-3-(trifluoromethyl)aniline Chemical compound NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 UTKUVRNVYFTEHF-UHFFFAOYSA-N 0.000 abstract 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 2
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical class N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 150000002430 hydrocarbons Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical group [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- GPKUICFDWYEPTK-UHFFFAOYSA-N methoxycyclohexatriene Chemical class COC1=CC=C=C[CH]1 GPKUICFDWYEPTK-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/108—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
REFERIDO A UN COMPUESTO DE FORMULA (I), DONDE R1, R2, R3, R4 Y R5 SON CADA UNO H, HALOGENO, CIANO, ENTRE OTROS, X1 ES -O-, -C(O)-, -S-, ENTRE OTROS, X2 ES ALQUILO C3-C5, ALQUENILO C3-C5, ALQUINILO C3-C5, CARBOCICLILO C4-C6, OPCIONALMENTE SUSTITUIDO POR UNO O MAS ALQUILOS, X3 ES -S-, -O-, -C(O)-, ENTRE OTROS, X4 ES -CH2- Y -NH-, DONDE -CH2- ESTA OPCIONALMENTE SUSTITUIDO POR ALQUILO, ALQUENILO Y HALOALQUILO, Y DONDE -NH- ESTA OPCIONALMENTE SUSTITUIDO POR ALQUILO, ALQUENILO, ALQUINILO, ENTRE OTROS, X5 ES -O-, -C(S)-,-C(O)-, ENTRE OTROS, X6 ES UN ENLAZADOR EL CUAL ES UN HIDROCARBURO, CON UNO O MAS ATOMOS DE N, OPCIONALMENTE SUSTITUIDO POR HALOGENO, HIDROXI, ALCOXI, ENTRE OTROS, ES UN ENLAZADOR CON 3 A 6 ATOMOS QUE PUENTEA X5 Y X7 O ES UN ENLAZADOR CON MAS DE 3 ATOMOS QUE PUENTEA X5 Y X7 DONDE 1 O 2 ATOMOS SON N, X7 ES -O-, -C(O)-, -S-, ENTRE OTROS, Z1 ES N Y CH, DONDE CH ESTA OPCIONALMENTE SUSTITUIDO POR HALOGENO, NITRO, CIANO, ENTRE OTROS, Z2 ES N Y CH, DONDE CH ESTA OPCIONALMENTE SUSTITUIDO POR ALQUILO, ALCOXI, HALOALQUILO, ENTRE OTROS, Z3, Z4 Y Z5 SON CADA UNO N Y CH, DONDE CH ESTA OPCIONALMENTE SUSTITUIDO POR HALOGENO, CIANO Y NITRO, ENTRE OTROS. SON COMPUESTO PREFERIDOS: 2-[TRANS-4-(4-NITRO-3-TRIFLUOROMETIL-FENILAMINO)-CICLOHEXILOXI]-1-[4-(4-TRIFLUOROMETIL-FENIL)-PIPERAZIN-1-IL]-ETANONA, 1-[4-(4-METOXI-FENIL)-PIPERAZIN-1-IL]-2-[TRANS-4-(4-NITRO-3-TRIFLUOROMETIL-FENILAMINO)-CICLOHEXILOXI]-ETANONA. SIENDO UTIL COMO AGENTES ANTIHELMINTICOS O COMO INTERMEDIARIOS
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1424207P | 2007-12-17 | 2007-12-17 | |
| EP08101961 | 2008-02-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20091453A1 true PE20091453A1 (es) | 2009-10-03 |
Family
ID=39563449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2008002081A PE20091453A1 (es) | 2007-12-17 | 2008-12-16 | Compuestos como agentes antihelminticos o como intermediarios en la preparacion de agentes antihelminticos |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8569495B2 (es) |
| EP (1) | EP2234973B1 (es) |
| CN (1) | CN101896459B (es) |
| AR (1) | AR069772A1 (es) |
| AU (1) | AU2008337482B2 (es) |
| BR (1) | BRPI0822033B1 (es) |
| CA (1) | CA2709407A1 (es) |
| ES (1) | ES2501544T3 (es) |
| NZ (1) | NZ586087A (es) |
| PE (1) | PE20091453A1 (es) |
| TW (1) | TW200938203A (es) |
| UY (1) | UY31539A1 (es) |
| WO (1) | WO2009077527A1 (es) |
| ZA (1) | ZA201004261B (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010114907A1 (en) | 2009-03-31 | 2010-10-07 | Vanderbilt University | Sulfonyl-azetidin-3-yl-methylamine amide analogs as glyt1 inhibitors, methods for making same, and use of same in treating psychiatric disorders |
| CA2813189C (en) * | 2010-09-29 | 2020-04-28 | Sk Biopharmaceuticals Co., Ltd. | Novel methylcyclohexane derivatives and uses thereof |
| EP2468096A1 (en) | 2010-12-21 | 2012-06-27 | Intervet International BV | Anthelmintic combinations |
| KR102151832B1 (ko) * | 2012-11-20 | 2020-09-03 | 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 | 구충제 화합물 및 조성물 및 이의 사용 방법 |
| FR3000065A1 (fr) * | 2012-12-21 | 2014-06-27 | Univ Lille Ii Droit & Sante | Composes bicycliques ayant une activite potentialisatrice de l'activite d'un antibiotique actif contre les mycobacteries-composition et produit pharmaceutiques comprenant de tels composes |
| EP3145925B1 (en) | 2014-05-19 | 2020-11-04 | Boehringer Ingelheim Animal Health USA Inc. | Anthelmintic compounds |
| AU2015286634A1 (en) * | 2014-07-11 | 2017-01-19 | Intervet Inc. | Use of anthelmintic agents against Dirofilaria immitis |
| WO2016005577A1 (en) * | 2014-07-11 | 2016-01-14 | Intervet International B.V. | Use of anthelmintic agents against dirofilaria immitis |
| EP3247701B1 (en) | 2015-01-20 | 2021-09-22 | Boehringer Ingelheim Animal Health USA Inc. | Anthelmintic compounds, compositions and method of using thereof |
| EP3468960B1 (en) | 2016-06-08 | 2022-03-23 | GlaxoSmithKline Intellectual Property Development Limited | Chemical compounds as atf4 pathway inhibitors |
| ES2747768T3 (es) | 2017-03-20 | 2020-03-11 | Forma Therapeutics Inc | Composiciones de pirrolopirrol como activadores de quinasa de piruvato (PKR) |
| ES2919779T3 (es) | 2017-06-20 | 2022-07-28 | Imbria Pharmaceuticals Inc | Derivado de 1-[(2,3,4-trimetoxifenil)metil]-piperazina, composiciones del mismo y métodos para aumentar la eficiencia del metabolismo cardíaco |
| CN107987012A (zh) * | 2018-01-29 | 2018-05-04 | 田元强 | 一种4-苄基哌啶类酰胺化合物及其在防治植物线虫病害中的应用 |
| WO2020061378A1 (en) | 2018-09-19 | 2020-03-26 | Forma Therapeutics, Inc. | Treating sickle cell disease with a pyruvate kinase r activating compound |
| WO2020061255A1 (en) | 2018-09-19 | 2020-03-26 | Forma Therapeutics, Inc. | Activating pyruvate kinase r |
| EP4497474A3 (en) | 2018-10-17 | 2025-04-23 | Imbria Pharmaceuticals, Inc. | Methods of treating rheumatic diseases using trimetazidine-based compounds |
| US20220378756A1 (en) | 2019-09-19 | 2022-12-01 | Forma Therapeutics, Inc. | Activating pyruvate kinase r |
| US11530184B2 (en) | 2020-06-30 | 2022-12-20 | Imbria Pharmaceuticals, Inc. | Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate |
| US11780811B2 (en) | 2020-06-30 | 2023-10-10 | Imbria Pharmaceuticals, Inc. | Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate |
| US12128035B2 (en) | 2021-03-19 | 2024-10-29 | Novo Nordisk Health Care Ag | Activating pyruvate kinase R |
| US11883396B2 (en) | 2021-05-03 | 2024-01-30 | Imbria Pharmaceuticals, Inc. | Methods of treating kidney conditions using modified forms of trimetazidine |
| CN117586207A (zh) * | 2023-11-27 | 2024-02-23 | 浙江东亚药业股份有限公司 | 一种酮康唑侧链的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB819681A (en) * | 1957-01-24 | 1959-09-09 | Wellcome Found | Improvements in and relating to quaternary ammonium compounds and the preparation thereof |
| GB1032251A (en) * | 1961-06-22 | 1966-06-08 | Wellcome Found | Piperazine compounds and their preparation |
| CH540236A (de) * | 1970-09-02 | 1973-08-15 | Agripat Sa | Verfahren zur Herstellung neuer Thioharnstoffe |
| US4247710A (en) * | 1978-02-08 | 1981-01-27 | Hoffmann-La Roche Inc. | Intermediate in the production of adrenergic blocking agents |
| DE19529604A1 (de) * | 1995-08-11 | 1997-02-13 | Bayer Ag | Endoparasitizide Mittel auf Basis von Didepsipeptiden, neue Didepsipeptide und ein Verfahren zu ihrer Herstellung |
| FR2740134B1 (fr) * | 1995-10-18 | 1998-01-09 | Pf Medicament | Derives d'amines cycliques d'aryl-piperazines, leur preparation et les compositions pharmaceutiques les contenant |
| AU2056800A (en) * | 1998-12-18 | 2000-07-03 | Du Pont Pharmaceuticals Company | Heterocyclic piperidines as modulators of chemokine receptor activity |
-
2008
- 2008-12-10 TW TW097148018A patent/TW200938203A/zh unknown
- 2008-12-16 NZ NZ586087A patent/NZ586087A/en not_active IP Right Cessation
- 2008-12-16 AU AU2008337482A patent/AU2008337482B2/en not_active Ceased
- 2008-12-16 CA CA2709407A patent/CA2709407A1/en not_active Abandoned
- 2008-12-16 US US12/808,897 patent/US8569495B2/en not_active Expired - Fee Related
- 2008-12-16 ES ES08863299.7T patent/ES2501544T3/es active Active
- 2008-12-16 CN CN2008801201693A patent/CN101896459B/zh not_active Expired - Fee Related
- 2008-12-16 EP EP08863299.7A patent/EP2234973B1/en active Active
- 2008-12-16 BR BRPI0822033A patent/BRPI0822033B1/pt not_active IP Right Cessation
- 2008-12-16 WO PCT/EP2008/067621 patent/WO2009077527A1/en not_active Ceased
- 2008-12-16 PE PE2008002081A patent/PE20091453A1/es not_active Application Discontinuation
- 2008-12-17 AR ARP080105480A patent/AR069772A1/es not_active Application Discontinuation
- 2008-12-17 UY UY31539A patent/UY31539A1/es unknown
-
2010
- 2010-06-15 ZA ZA2010/04261A patent/ZA201004261B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA201004261B (en) | 2011-02-23 |
| AU2008337482A1 (en) | 2009-06-25 |
| EP2234973A1 (en) | 2010-10-06 |
| BRPI0822033B1 (pt) | 2018-12-11 |
| CN101896459B (zh) | 2013-07-24 |
| AR069772A1 (es) | 2010-02-17 |
| AU2008337482B2 (en) | 2013-09-12 |
| TW200938203A (en) | 2009-09-16 |
| ES2501544T3 (es) | 2014-10-02 |
| US20110021506A1 (en) | 2011-01-27 |
| UY31539A1 (es) | 2009-08-03 |
| EP2234973B1 (en) | 2014-07-02 |
| WO2009077527A1 (en) | 2009-06-25 |
| US8569495B2 (en) | 2013-10-29 |
| NZ586087A (en) | 2011-08-26 |
| CA2709407A1 (en) | 2009-06-25 |
| BRPI0822033A2 (pt) | 2015-07-21 |
| CN101896459A (zh) | 2010-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20091453A1 (es) | Compuestos como agentes antihelminticos o como intermediarios en la preparacion de agentes antihelminticos | |
| AR064824A1 (es) | Derivados de espirocromanona sustituidos | |
| PE20060627A1 (es) | Derivados de pirazol condensado como agonistas de los receptores cannabinoides cb1 y/o cb2 | |
| MY137761A (en) | The use of n-arylhdrazine derivatives for combating non-crop pests | |
| AR066210A1 (es) | Proceso para producir compuesto amida | |
| EA200300595A1 (ru) | Соединения пиперазинилпиразинов в качестве антагонистов серотонин 5-ht2 рецептора | |
| AR047456A1 (es) | Derivados de amidas, procesos para su preparacion y uso como insecticidas | |
| PE20050747A1 (es) | Pirimidinas herbicidas | |
| ECSP055974A (es) | Síntesis de cloruros de 4 amino-2-butenoil y su uso en la preparación de 3-ciano quinolinas | |
| AR068359A1 (es) | Derivados de quinoleina sustituida, procesos para su preparacion e intermediarios de sintesis, una composicion fungicida que los comprende y un metodo para combatir o controlar hongos fitopatogenicos. | |
| BRPI0413233A (pt) | novos compostos | |
| PE20061298A1 (es) | Compuestos derivados de dihidrobenzofurano como agonistas del receptor de serotonina 5-ht2c | |
| AR068115A1 (es) | Derivado del acido pirazolcarboxilico metodo de produccion del mismo y fungicida | |
| WO2008051533A3 (en) | Benzimidazole compounds | |
| PE20081496A1 (es) | Derivados de 2,5-dihidro-3-h-pirazolo[4,3-c]piridazin-3-ona sustituidos como antagonistas de los receptores cb1 | |
| DOP2010000226A (es) | Compuestos triciclicos que tienen actividad antagonista de factor de liberacion de corticotropina y composiciones farmaceuticas que contienen los mismos | |
| AR049883A1 (es) | Antagonistas de cgrp seleccionados, procedimientos para su preparacion, y su empleo como medicamentos | |
| MA31987B1 (fr) | Composes pyridylmethyle sulfonamide | |
| AR056103A1 (es) | Compuestos de(piran-piperidinil)benzimidazol, composiciones farmaceuticas que los comprenden, proceso de preparacion y usos en el tratamiento de afecciones mediadas por agonistas del receptor muscarinico m1 | |
| AR044662A1 (es) | Compuestos de azetidina | |
| WO2008111632A1 (ja) | ２，２，４－トリメチル－６－フェニル－１，２－ジヒドロキノリン誘導体からなるグルココルチコイド受容体アゴニスト | |
| AR066603A1 (es) | Derivados de arilamida pirimidona | |
| MX2010012303A (es) | Agonista de receptor de glucocorticoide compuesto de derivado de 2,2,4-trimetil-6-fenil-1,2-dihidroquinolina que tiene un grupo oxi sustituido. | |
| PE20060734A1 (es) | Derivado de pirrol sustituido como antagonistas del receptor de androgenos | |
| PE20190657A1 (es) | Compuestos de indazol para usar en lesiones de tendones y/o ligamentos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |